|
北海康成製藥有限公司, 01228.HK - 綜合損益表 |
2021-12 |
2020-12 |
2019-12 |
2014-12 |
2013-12 |
2012-12 |
2011-12 |
2010-12 |
2009-12 |
2008-12 |
2007-12 |
2006-12 |
2005-12 |
營業額 |
31,161 |
12,032 |
1,469 |
421,127 |
773,302 |
119,466 |
49,550 |
53,677 |
16,800 |
65,940 |
709,331 |
489,325 |
515,877 |
經營溢利 |
-1,039,814 |
-837,402 |
-217,675 |
-989,279 |
-265,217 |
-149,696 |
-661,232 |
81,571 |
683,220 |
-792,924 |
1,226,497 |
-25,298 |
43,424 |
非經營/ 特殊項目 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
-11,338 |
0 |
0 |
聯營公司 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
除稅前經營溢利 |
-1,077,006 |
-846,043 |
-217,675 |
-989,279 |
-265,217 |
-149,696 |
-661,232 |
81,571 |
683,220 |
-792,924 |
1,215,159 |
-25,298 |
43,424 |
稅項 |
0 |
0 |
0 |
-74,702 |
0 |
0 |
0 |
19 |
0 |
1,759 |
4,586 |
1,069 |
3,749 |
少數股東權益 |
0 |
0 |
0 |
-121,515 |
-3,340 |
-17,320 |
-2,947 |
0 |
78,132 |
-241,763 |
92,736 |
0 |
0 |
股東應占溢利 |
-1,077,006 |
-846,043 |
-217,675 |
-793,062 |
-261,877 |
-132,376 |
-658,285 |
74,461 |
586,449 |
-639,881 |
1,117,837 |
-26,367 |
39,675 |
貨幣 |
人民幣 |
人民幣 |
人民幣 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
單位 |
千 |
千 |
千 |
千 |
千 |
主要項目 |
折舊 |
15,706 |
17,839 |
3,595 |
106,481 |
533 |
2,881 |
4,305 |
1,608 |
2,094 |
38,384 |
24,934 |
20,830 |
18,490 |
利息 |
3,079 |
3,794 |
1,349 |
8,962 |
0 |
1,591 |
450 |
1,192 |
14,263 |
38,538 |
11,338 |
4,419 |
2,609 |
利息撥作發展資本 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
處置/重估固定資產 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
稅率(%) |
|
|
|
7.55 |
|
|
|
0.02 |
0.31 |
|
0.38 |
|
8.63 |
營業額增長(%) |
158.98 |
719.06 |
0.0 |
-45.54 |
547.3 |
141.1 |
-7.69 |
-87.55 |
-14.49 |
-28.92 |
44.96 |
-5.15 |
5.98 |
股東應占溢利增長(%) |
-27.3 |
-288.67 |
0.0 |
-202.84 |
-97.83 |
79.89 |
0.0 |
-87.3 |
|
|
|
|
-59.82 |
核數師意見 |
1 |
0 |
0 |
1 |
1 |
1 |
1 |
1 |
1 |
2 |
1 |
1 |
1 |
說明:1代表無保留意見;2代表保留意見;3代表修改意見
|
|